BMG Pharma SpA

BMG Pharma SpA, Milano, Italy: completion of a € 10m share capital. BMG Pharma is an Italian Specialty Pharma which boasts a rich pipeline in next-generation dermal fillers based on novel patented combinations of HA with butyric, folic and lipoic acids to optimize the anti-inflammatory, moisturizing, tissue regenerative properties and hence produce better results in terms of resistance to hyaluronidase, neocollagenesis, neoelastogenesis and longevity of action. Founded in 2010 by an ex-Head of Sinclair’s Corporate Development, Dr. Mastrodonato, BMG has focused its portfolio on specialties in which it has established recognized core expertise such as for instance dermatology / woundhealing, women’s health, osteoarthritis, oral-buccal care and a rich pipeline of medical aesthetics devices such as injectable dermal fillers as well as lifting threads. The company benefits from a recurrent stream of sustainable revenues with well-established niche dermatology and dermocosmetics products, which are clinically-evidenced, supported by IP as well as a network of very-well-known Key Opinion Leaders in Dermatology and Aesthetics. We raised € 10m on an undisclosed valuation from Italian Pharmaceutical Partners in Dermatology and Dental/Oral-buccal care.